Publications  – Professor Francisco Antunes

Internacional Journals

Clinical relevance of multiple SNPs in Pneumocystis jirovecii pneumonia: Development of a multiplex-PCR/SBE methodology. Esteves F, Gaspar J, de Sousa B, Antunes F, Mansinho K, Matos O. J Clin Microbiol 2011; 49(5): 1810-5

The case of the disappearing mycobacteria in Ziehl-Neelsen-stained smears. Hänscheid T, Badura R, Fernandes ML, Antunes F, Cristino JM. Int J Infect Dis 2011; 15(4): e291

Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. Soares RS, Tendeiro R, Antunes F, Victorino RM, Sousa AE et al. J Virol 2011; 85(5): 2429-38

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. Eron JJ Jr, Rockstroh JK, Antunes F; QDMRK Investigators. Lancet Infect Dis 2011; 11(12): 907-15

Genetic diversity and drug resistance profiles in HIV type 1 and HIV type 2-infected patients from Cape Verde islands. Oliveira V, Bártolo I, Antunes F, Taveira N et al. AIDS Res Hum Retroviruses 2011; 19 [Epub ahead of print]

Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. Reekie J, Gatell JM, Antunes F; EuroSIDA in EuroCoord. AIDS 2011; 25(18): 2259-68

Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Dwyer DE; INSIGHT Influenza Study Group. Vaccine 2011; 29 (Suppl 2): B56-62

Hepatitis delta in HIV-infected individuals in Europe. Soriano V, Grint D, Antunes F et al. AIDS 2011; 25(16): 1987-92

A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy. Paredes R, Puertas MC, Antunes F; EuroSIDA Study Group. J Infect Dis 2011; 204(5): 741-52

Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors. Kruk A, Bannister W, Antunes F; EuroSIDA study group. AIDS 2011; 25(12): 1505-13

Population mobility and the changing epidemics of HIV-2 in Portugal. Carvalho A, Valadas E, Antunes F et al. HIV Med 2011; 4

Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial. Soriano V, Arastéh K, Antunes F; ARTEN investigators. Antivir Ther 2011; 16(3): 339-48

Acute kidney injury in hospitalized HIV-infected patients: a cohort analysis. Lopes JA, Melo MJ, Antunes F et al. Nephrol Dial Transplant 2011; 26(12): 3888-94

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. Viard JP, Souberbielle JC, Antunes F; EuroSIDA Study Group. AIDS 2011; 25(10): 1305-15

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group. Benard A, van Sighem A, Valadas E, Antunes F; ACHIEV2E Collaboration Study Group. Clin Infect Dis 2011; 52(10): 1257-66

A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study. Kowalska JD, Mocroft A, Antunes F; Eurosida Study Group. HIV Clin Trials 2011; 12(2): 109-17

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy. Bannister WP, Cozzi-Lepri A, Antunes F; EuroSIDA group. J Antimicrob Chemother 2011; 66(4): 901-11

Antiretroviral therapy for naïve and for treatment-experienced HIV patients, and prevention of HIV transmission. Antunes F. Curr Opin HIV AIDS 2011; 6 (Suppl 1):S1-2

Books 

Manual sobre Sida (4ª edição 2011) – Editor Francisco Antunes
Estágios em Medicina Tropical – uma experiência de ensino pré-graduado (2011) – Editor Francisco Antunes

Publications –  Professor Emília Valadas 2011, as an author

Carvalho A, Valadas E, França L, Carvalho C, Aleixo M, Mendez J, et al. Population mobility and the changing epidemics of HIV-2 in Portugal. HIV Med. 2011 Dec 4. doi: 10.1111/j.1468-1293.2011.00963.x.

Oliveira V, Bártolo I, Borrego P, Rocha C, Valadas E, Barreto J, et al. Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands. AIDS Res Hum Retroviruses. 2011 Sep 19.

Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, et al. Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group. Clin Infect Dis. 2011;52(10):1257-66.

Soares RS, Tendeiro R, Foxall RB, Baptista AP, Cavaleiro R, Gomes P, et al. Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. J Virol. 2011;85(5):2429-38.

Publicaçtions– Professor Emília Valadas 2011, as a researcher

Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C, et al. A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy. J Infect Dis. 2011;204(5):741-52.

Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, et al. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors. AIDS. 2011;25(12):1505-13.

Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS. 2011;25(10):1305-15.

Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, et al. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study. HIV Clin Trials. 2011;12(2):109-17.

Bannister WP, Cozzi-Lepri A, Kjær J, Clotet B, Lazzarin A, Viard JP, et al. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy. J Antimicrob Chemother. 2011;66(4):901-11.

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, et al. Predictors of bacterial pneumonia in evaluation of subcutaneous interleukin-2 in a randomized international trial (ESPRIT). HIV Med. 2011;12(4):219-27.

Reekie J, Reiss P, Ledergerber B, Sedlacek D, Parczewski M, Gatell J, et al. A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study. HIV Med. 2011;12(5):259-68.